Back to top
more

Insulet (PODD)

(Delayed Data from NSDQ)

$204.42 USD

204.42
1,270,861

+11.84 (6.15%)

Updated Aug 28, 2024 04:00 PM ET

After-Market: $202.65 -1.77 (-0.87%) 7:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (98 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for PODD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Insulet Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 704 675 792 948 376
Receivables 360 206 161 84 83
Notes Receivable 0 0 0 0 0
Inventories 403 347 303 154 101
Other Current Assets 116 87 74 63 31
Total Current Assets 1,583 1,314 1,330 1,249 591
Net Property & Equipment 665 600 537 479 399
Investments & Advances 0 0 0 0 58
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 150 127 76 69 53
Deposits & Other Assets 190 210 106 77 41
Total Assets 2,588 2,251 2,049 1,873 1,143
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 19 31 38 54 55
Current Portion Long-Term Debt 49 28 25 16 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 383 306 166 138 103
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 451 365 229 208 158
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 888
Long-Term Debt 1,366 1,374 1,249 1,044 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 38 36 15 18 21
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,856 1,775 1,493 1,269 1,067
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 1,103 1,041 1,208 1,264 749
Retained Earnings -378 -584 -650 -666 -672
Other Equity 8 20 -2 6 -1
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 733 476 556 604 76
Total Liabilities & Shareholder's Equity 2,588 2,251 2,049 1,873 1,143
Total Common Equity 733 476 556 604 76
Shares Outstanding 69.80 69.40 68.90 65.90 61.80
Book Value Per Share 10.50 6.86 8.07 9.16 1.23

Fiscal Year End for Insulet Corporation falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents 821 751 704 685 660
Receivables 349 321 360 270 251
Notes Receivable 0 0 0 0 0
Inventories 431 431 403 411 411
Other Current Assets 148 116 116 105 100
Total Current Assets 1,749 1,618 1,583 1,471 1,422
Net Property & Equipment 678 668 665 649 602
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 141 0 0 0 0
Intangibles 150 150 150 151 151
Deposits & Other Assets 164 188 190 196 212
Total Assets 2,882 2,624 2,588 2,468 2,386
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable 0 0 0 0 0
Accounts Payable 77 76 19 78 108
Current Portion Long-Term Debt 38 39 49 50 29
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 371 318 383 324 288
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 486 432 451 451 425
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,360 1,363 1,366 1,371 1,369
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 37 38 38 38
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,883 1,833 1,856 1,860 1,832
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 1,141 1,118 1,103 1,081 1,071
Retained Earnings -138 -327 -378 -481 -533
Other Equity -4 -1 8 8 16
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 998 791 733 608 554
Total Liabilities & Shareholder's Equity 2,882 2,624 2,588 2,468 2,386
Total Common Equity 998 791 733 608 554
Shares Outstanding 70.00 70.00 69.80 69.80 69.70
Book Value Per Share 14.26 11.30 10.50 8.70 7.95